PL155084B1 - A method of monoclonic antibodies generating and the useof theses antibodies in distributions based on immulogical affinity - Google Patents

A method of monoclonic antibodies generating and the useof theses antibodies in distributions based on immulogical affinity

Info

Publication number
PL155084B1
PL155084B1 PL1987267401A PL26740187A PL155084B1 PL 155084 B1 PL155084 B1 PL 155084B1 PL 1987267401 A PL1987267401 A PL 1987267401A PL 26740187 A PL26740187 A PL 26740187A PL 155084 B1 PL155084 B1 PL 155084B1
Authority
PL
Poland
Prior art keywords
antibodies
hiv
peptides
peptide
monoclonal antibodies
Prior art date
Application number
PL1987267401A
Other languages
English (en)
Polish (pl)
Other versions
PL267401A1 (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL267401A1 publication Critical patent/PL267401A1/xx
Publication of PL155084B1 publication Critical patent/PL155084B1/pl

Links

Classifications

    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
    • F04B25/00—Multi-stage pumps
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • AIDS & HIV (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Mechanical Engineering (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL1987267401A 1986-08-20 1987-08-20 A method of monoclonic antibodies generating and the useof theses antibodies in distributions based on immulogical affinity PL155084B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89827386A 1986-08-20 1986-08-20
US4502687A 1987-05-01 1987-05-01
US6799687A 1987-06-29 1987-06-29

Publications (2)

Publication Number Publication Date
PL267401A1 PL267401A1 (en) 1988-07-21
PL155084B1 true PL155084B1 (en) 1991-10-31

Family

ID=27366600

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1987267401A PL155084B1 (en) 1986-08-20 1987-08-20 A method of monoclonic antibodies generating and the useof theses antibodies in distributions based on immulogical affinity

Country Status (28)

Country Link
JP (1) JPS6485928A (enrdf_load_stackoverflow)
KR (1) KR920008744B1 (enrdf_load_stackoverflow)
AT (1) AT398080B (enrdf_load_stackoverflow)
AU (1) AU616156B2 (enrdf_load_stackoverflow)
BE (1) BE1000811A4 (enrdf_load_stackoverflow)
CH (1) CH675728A5 (enrdf_load_stackoverflow)
CS (1) CS275838B6 (enrdf_load_stackoverflow)
DE (1) DE3727703A1 (enrdf_load_stackoverflow)
DK (1) DK433087A (enrdf_load_stackoverflow)
ES (1) ES2010727A6 (enrdf_load_stackoverflow)
FI (1) FI873553L (enrdf_load_stackoverflow)
FR (1) FR2603107B1 (enrdf_load_stackoverflow)
GB (1) GB2196634B (enrdf_load_stackoverflow)
GR (1) GR871298B (enrdf_load_stackoverflow)
HU (1) HU214439B (enrdf_load_stackoverflow)
IE (1) IE60671B1 (enrdf_load_stackoverflow)
IL (1) IL83580A (enrdf_load_stackoverflow)
IT (1) IT1222518B (enrdf_load_stackoverflow)
LU (1) LU86972A1 (enrdf_load_stackoverflow)
NL (1) NL8701950A (enrdf_load_stackoverflow)
NO (2) NO300462B1 (enrdf_load_stackoverflow)
NZ (1) NZ221440A (enrdf_load_stackoverflow)
OA (1) OA08652A (enrdf_load_stackoverflow)
PL (1) PL155084B1 (enrdf_load_stackoverflow)
PT (1) PT85567B (enrdf_load_stackoverflow)
SE (1) SE506025C2 (enrdf_load_stackoverflow)
YU (1) YU152587A (enrdf_load_stackoverflow)
ZW (1) ZW15487A1 (enrdf_load_stackoverflow)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP96A (en) * 1986-06-03 1990-08-12 The Usa Dept Of Commerce Small peptides which inhibit binding to T-4 receptors and act as immunogens.
AU625720B2 (en) * 1987-05-01 1992-07-16 Genetic Systems Corporation Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
US5834599A (en) * 1987-05-29 1998-11-10 Tanox Biosystems, Inc. Immunoconjugates which neutralize HIV-1 infection
US6657050B1 (en) 1987-05-29 2003-12-02 Tanox, Inc. Chimeric viral-neutralizing immunoglobulins
US5981278A (en) * 1987-05-29 1999-11-09 Tanox, Inc. Chimeric monoclonal antibodies which neutralize HIV-1 infection and their applications in therapy and prevention for AIDS
DE3853779T2 (de) * 1987-05-29 1995-09-07 Baylor College Medicine Hiv-1 neutralisierende monoklonale antikörper.
JP2569185B2 (ja) * 1988-01-26 1997-01-08 アメリカ合衆国 抗ｈｉｖ応答を喚起する合成抗原
CA1341285C (en) * 1988-02-12 2001-08-14 Chang Yi Wang Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines
IL90048A0 (en) * 1988-04-25 1989-12-15 Merck & Co Inc Recombinant gag precursor of hiv,its preparation and its use as aids vaccine
US5562905A (en) * 1988-04-26 1996-10-08 E. I. Du Pont De Nemours And Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
EP0339504A3 (en) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
FR2632310B1 (fr) * 1988-06-06 1992-04-10 Pasteur Institut Peptides ayant des proprietes protectrices d'un virus pathogene du type hiv dans des cellules sensibles
IL91843A0 (en) * 1988-10-03 1990-06-10 Repligen Corp Hiv proteins and peptides useful in the diagnosis,prophylaxis aids or therapy of aids
EP0421626A1 (en) * 1989-09-19 1991-04-10 Merck & Co. Inc. Vaccine for aids and hepatitis B
SE9000333D0 (sv) * 1990-01-31 1990-01-31 Britta Wahren Monoklonal antikropp
SE468168B (sv) * 1990-02-20 1992-11-16 Replico Medical Ab Hiv-1, p24 peptider, diagnostiska antigener och foerfarande foer saerskiljande diagnostik av preliminaert hiv-1 positiva serumprov
JPH03271233A (ja) * 1990-03-19 1991-12-03 Inst Pasteur ウイルスエンベロープ糖タンパク質及びその糖タンパク質の中和エピトープに対応するペプチドの間の相乗作用による、ウイルス性感染に対する防御の誘発
CA2047042A1 (en) * 1990-07-19 1992-01-20 John Hannah Cyclic hiv principal neutralizing determinant peptides
CA2047078A1 (en) * 1990-07-19 1992-01-20 Steven S. Bondy Cyclic hiv principal neutralizing determinant peptides
JPH05310785A (ja) * 1991-09-30 1993-11-22 Nitto Denko Corp Ｈｉｖ関連環状ペプチドおよびこれを固定化した吸着体
AU684713B2 (en) * 1992-03-27 1998-01-08 Advanced Immunit, Inc. Peptide T and related peptides in the treatment of inflammatory bowel disease
PL1976548T3 (pl) * 2005-12-09 2015-01-30 Vectus Biosystems Ltd Fragmenty VIP i ich kompozycje
KR101215215B1 (ko) 2008-09-02 2012-12-24 니혼도꾸슈도교 가부시키가이샤 스파크 플러그
KR102727239B1 (ko) * 2022-09-07 2024-11-07 한국세라믹기술원 산화 마그네슘　분말 및 그의 제조방법

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9328391B1 (en) * 1984-08-22 2016-05-03 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Cloning and expression of HIV-1 DNA
DE3588251T2 (de) * 1984-10-18 2006-01-12 Institut Pasteur DNS-Fragmente des GAG-Gens von LAV
GB8501473D0 (en) * 1985-01-21 1985-02-20 Pasteur Institut Cloned dna sequences
CA1341423C (en) * 1984-10-31 2003-03-04 Paul A. Luciw Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
WO1986006099A1 (en) * 1985-04-08 1986-10-23 Genetic Systems Corporation EXPRESSION AND DIAGNOSTIC USE OF gag ENCODED PEPTIDES WHICH ARE IMMUNOLOGICALLY REACTIVE WITH ANTIBODIES TO LAV
IE64785B1 (en) * 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
DK171119B1 (da) * 1985-04-19 1996-06-17 Hoffmann La Roche AIDS-viruskappeprotein, ekspressionsvektor bærende viruskappeproteinet, transformanter transformeret med ekspressionsvektoren, fremgangsmåde til fremstilling af viruskappeproteinet, fremgangsmåde til detektion af AIDS-antistoffer, fremgangsmåde til bestemmelse af AIDS-virus, vaccine mod AIDS, antistoffer mod viruskappeproteinet samt anvendelse af dette til fremstilling af en vaccine og til testnin
KR910002374B1 (ko) * 1985-04-29 1991-04-20 제네틱 시스템즈 코포레이션 Aids 관련질병의 검출을 위한 합성항원
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
WO1987002775A1 (en) * 1985-10-24 1987-05-07 Southwest Foundation For Biomedical Research Synthetic peptides and use for diagnosis and vaccination for aids and arc
WO1987002988A1 (en) * 1985-11-07 1987-05-21 President And Fellows Of Harvard College T-cell lymphotrophic virus protein and assay
US4772547A (en) * 1986-02-03 1988-09-20 Hoffmann-La Roche Inc. HTLV-III envelope peptides
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
IE63109B1 (en) * 1986-06-23 1995-03-22 Genetic Systems Corp Human monoclonal antibody to lymphadenopathy-associated virus
EP0525828A3 (en) * 1986-08-01 1993-02-24 Repligen Corporation Recombinant polypeptides and their uses, including assay for aids virus
WO1988005051A1 (en) * 1986-12-30 1988-07-14 United States Of America, Represented By The Unite Synthetic peptides which induce cellular immunity of the aids virus and aids viral proteins

Also Published As

Publication number Publication date
FR2603107B1 (fr) 1992-04-24
ATA208987A (de) 1994-01-15
HU214439B (hu) 1998-03-30
NO873495D0 (no) 1987-08-19
NO873495L (no) 1988-02-22
IL83580A0 (en) 1988-01-31
IT8721678A0 (it) 1987-08-19
NZ221440A (en) 1991-11-26
GB2196634A (en) 1988-05-05
YU152587A (sh) 1992-09-07
SE506025C2 (sv) 1997-11-03
SE8703225D0 (sv) 1987-08-19
BE1000811A4 (fr) 1989-04-11
SE8703225L (sv) 1988-02-21
FR2603107A1 (fr) 1988-02-26
DK433087D0 (da) 1987-08-19
NO300462B1 (no) 1997-06-02
NO302176B1 (no) 1998-02-02
ZW15487A1 (en) 1988-09-14
PT85567B (pt) 1991-02-08
JPS6485928A (en) 1989-03-30
IE60671B1 (en) 1994-08-10
DK433087A (da) 1988-02-21
DE3727703A1 (de) 1988-05-05
IL83580A (en) 1992-11-15
PL267401A1 (en) 1988-07-21
GB2196634B (en) 1991-05-15
KR920008744B1 (ko) 1992-10-09
IT1222518B (it) 1990-09-05
GR871298B (en) 1988-01-12
NO934897L (no) 1993-12-29
FI873553A7 (fi) 1988-02-21
IE872219L (en) 1988-02-20
NO934897D0 (no) 1993-12-29
CS275838B6 (en) 1992-03-18
AT398080B (de) 1994-09-26
FI873553A0 (fi) 1987-08-17
ES2010727A6 (es) 1989-12-01
GB8719587D0 (en) 1987-09-23
AU616156B2 (en) 1991-10-24
OA08652A (fr) 1988-11-30
HUT44619A (en) 1988-03-28
NL8701950A (nl) 1988-03-16
PT85567A (en) 1987-09-01
LU86972A1 (fr) 1988-03-02
AU7720187A (en) 1988-05-19
FI873553L (fi) 1988-02-21
CH675728A5 (enrdf_load_stackoverflow) 1990-10-31
CS8706136A2 (en) 1990-08-14
KR890002547A (ko) 1989-04-10

Similar Documents

Publication Publication Date Title
US5166050A (en) Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections
US6335017B1 (en) Compositions and methods for treating viral infections
PL155084B1 (en) A method of monoclonic antibodies generating and the useof theses antibodies in distributions based on immulogical affinity
US5834599A (en) Immunoconjugates which neutralize HIV-1 infection
WO1994028929A1 (en) Hiv envelope polypeptides
US5854400A (en) Monoclonal antibodies which neutralize HIV-1 infection
EP0492560B1 (en) Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of HIV-1, and related peptides
WO1991009625A1 (en) Monoclonal antibodies which neutralize hiv-1 infection and their anti-idiotypes
WO1989010416A1 (en) PROTECTIVE PEPTIDES DERIVED FROM HUMAN IMMUNODEFICIENCY VIRUS-1 gp160
WO1989005821A1 (en) Hiv-related antigens and antibodies
AU2006200454B2 (en) Compositions and methods for treating viral infections
WO1989005820A1 (en) Hiv-related antigens and antibodies
JP2007534615A (ja) Ｈｉｖ免疫原性複合体
PL161520B1 (pl) Sposób wytwarzania nowego peptydu PL
AU2004201321A1 (en) Compositions and methods for treating viral infections
AU2006200455A1 (en) Compositions and methods for treating viral infections
AU2004208648A1 (en) Compositions and methods for treating infections
MXPA99003380A (en) Compositions and methods for treating viral infections